The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines-Reference-Cited by-同舟云学术

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines

Published:2022-04-26 Issue:2 Volume:13 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

McLean Gary¹^ORCID,Kamil Jeremy²^ORCID,Lee Benhur³^ORCID,Moore Penny⁴⁵^ORCID,Schulz Thomas F.⁶⁷⁸^ORCID,Muik Alexander⁹^ORCID,Sahin Ugur⁹^ORCID,Türeci Özlem⁹,Pather Shanti⁹^ORCID

Affiliation:

1. School of Human Sciences, London Metropolitan University and National Heart and Lung Institute, Imperial College London, London, United Kingdom

2. Louisiana State University Health, Shreveport, Louisiana, USA

3. Icahn School of Medicine at Mount Sinai, New York, New York, USA

4. Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa

5. MRC Antibody Immunity Research Unit, School of Pathology, The University of the Witwatersrand, Johannesburg, South Africa

6. Institute of Virology, Hannover Medical School, Hannover, Germany

7. Cluster of Excellence 2155 RESIST, Hannover, Germany

8. German Centre for Infection Research, Hannover-Braunschweig Site, Germany

9. BioNTech, Mainz, Germany

Abstract

The emergence of several new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in recent months has raised concerns around the potential impact on ongoing vaccination programs. Data from clinical trials and real-world evidence suggest that current vaccines remain highly effective against the alpha variant (B.1.1.7), while some vaccines have reduced efficacy and effectiveness against symptomatic disease caused by the beta variant (B.1.351) and the delta variant (B.1.617.2); however, effectiveness against severe disease and hospitalization caused by delta remains high.

Funder

BioNtech

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mbio.02979-21

Reference187 articles.

1. CoVariants. 2022. CoVariants. https://covariants.org/. Accessed 14 January 2022.

2. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection

3. Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2

4. Discovery of an RNA virus 3'->5' exoribonuclease that is critically involved in coronavirus RNA synthesis

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis;Frontiers in Molecular Biosciences;2024-09-06

2. Immunomics in one health: understanding the human, animal, and environmental aspects of COVID-19;Frontiers in Immunology;2024-09-04

3. A Single-center Experience With >200 Lung Transplant Recipients With COVID-19 Infection;Transplantation Direct;2024-08-29

4. Immune and inflammation features of severe and critical Omicron infected patients during Omicron wave in China;BMC Infectious Diseases;2024-08-09

5. Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination;Cell Reports Medicine;2024-08